Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis
US7033606B1 · kind B1 · utility
23Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1999 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | Jul 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4858
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a pharmaceutical composition designed to adhere to a mucous membrane for preventing or treating radiotherapy-related and chemotherapy-related mucositis, induced by radiotherapy or combined radiochemotherapy, comprising an effective amount of an antiradical compound mixed with a vehicle, which is liquid at room temperature and gels at the mucous membrane temperature and capable of adhering to the mucous membrane by its gelled status.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.